Search for: "Figures v. Figures" Results 501 - 520 of 13,861
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Jul 2024, 11:08 am by Richard Hunt
Lactose intolerance figured as well in Jackson v. [read post]
5 Jul 2024, 12:30 pm by John Ross
The Supreme Court's affirmation of the ancient common law right of trial by jury in SEC v. [read post]
4 Jul 2024, 9:05 pm by renholding
The last time I was in Poland was approximately three decades ago. [read post]
4 Jul 2024, 6:53 pm by Mark Tushnet
The puzzle is about how to think about figuring out the answer. [read post]
3 Jul 2024, 3:00 am by Greg Lambert
In this episode of The Geek in Review, hosts Marlene Gebauer and Greg Lambert sit down for a one-on-one conversation to catch up on their recent vacations and discuss some of the latest developments in the legal industry. [read post]
Several national decisions, as well as the UPC CoA decision in Nanostring v 10x Genomics were cited. [read post]
1 Jul 2024, 3:13 am by Rose Hughes
May the description and figures be consulted when interpreting the claims to assess patentability and, if so, may this be done generally or only if the person skilled in the art finds a claim to be unclear or ambiguous when read in isolation? [read post]
28 Jun 2024, 5:59 pm
My own earlier essays may be accessed here: Cuba Sonic Weapons Affair (43)   Transcript 0:00 Robert but becknell is a retired marine officer who worked for nine years as a NATO civilian Allied 0:06 command transformation before transitioning to private practice and consultancy he has a JD from Maryland 0:12 law an llm from Harvard Law and an MSC from the University of Oxford he resides in North Fork Virginia Mark as a 0:19 Washington DC National Security… [read post]
28 Jun 2024, 12:23 pm by Guest Author
The answer, I think, is “figure it out on your own until we tell you otherwise. [read post]
27 Jun 2024, 9:07 pm by Adam Levitin
Because of the opt-out, the revised plan will have two different payout tiers—one for those who opt-out and one for those who don’t—but the total dollar figure for the revised plan will likely be materially the same, although I would not be surprised to see the Sacklers will kick in a bit more money to reduce the number of opt-outs (and they can afford to with another couple of years of investment earnings while the appeals were pending). [read post]